UBS Group’s Vyant Bio, Inc. Common Stock VYNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-5,463
Closed -$3.17K 9048
2023
Q1
$3.17K Buy
5,463
+508
+10% +$295 ﹤0.01% 7264
2022
Q4
$3.47K Buy
4,955
+2,158
+77% +$1.51K ﹤0.01% 8310
2022
Q3
$8K Sell
2,797
-690
-20% -$1.97K ﹤0.01% 7700
2022
Q2
$16K Buy
3,487
+1,629
+88% +$7.48K ﹤0.01% 6206
2022
Q1
$13K Sell
1,858
-150
-7% -$1.05K ﹤0.01% 7060
2021
Q4
$14K Buy
+2,008
New +$14K ﹤0.01% 7266
2021
Q3
Sell
-260
Closed -$5K 9059
2021
Q2
$5K Buy
260
+97
+60% +$1.87K ﹤0.01% 7492
2021
Q1
$4K Buy
+163
New +$4K ﹤0.01% 7412
2020
Q4
Sell
-112
Closed -$2K 7778
2020
Q3
$2K Sell
112
-156
-58% -$2.79K ﹤0.01% 6831
2020
Q2
$4K Sell
268
-307
-53% -$4.58K ﹤0.01% 6634
2020
Q1
$8K Sell
575
-33
-5% -$459 ﹤0.01% 6186
2019
Q4
$18K Sell
608
-202
-25% -$5.98K ﹤0.01% 5887
2019
Q3
$13K Buy
810
+247
+44% +$3.96K ﹤0.01% 6052
2019
Q2
$14K Buy
563
+561
+28,050% +$14K ﹤0.01% 5989
2019
Q1
$0 Sell
2
-126
-98% ﹤0.01% 7231
2018
Q4
$5K Buy
128
+102
+392% +$3.98K ﹤0.01% 6646
2018
Q3
$4K Sell
26
-31
-54% -$4.77K ﹤0.01% 6670
2018
Q2
$7K Sell
57
-349
-86% -$42.9K ﹤0.01% 6436
2018
Q1
$100K Sell
406
-624
-61% -$154K ﹤0.01% 4391
2017
Q4
$285K Sell
1,030
-830
-45% -$230K ﹤0.01% 3796
2017
Q3
$753K Buy
1,860
+491
+36% +$199K ﹤0.01% 3193
2017
Q2
$811K Buy
1,369
+1,367
+68,350% +$810K ﹤0.01% 3060
2017
Q1
$1K Sell
2
-3
-60% -$1.5K ﹤0.01% 6555
2016
Q4
$1K Sell
5
-6
-55% -$1.2K ﹤0.01% 6661
2016
Q3
$3K Hold
11
﹤0.01% 6380
2016
Q2
$3K Sell
11
-72
-87% -$19.6K ﹤0.01% 6442
2016
Q1
$36K Buy
83
+4
+5% +$1.74K ﹤0.01% 4949
2015
Q4
$39K Buy
79
+14
+22% +$6.91K ﹤0.01% 4963
2015
Q3
$77K Buy
65
+50
+333% +$59.2K ﹤0.01% 4388
2015
Q2
$26K Buy
15
+6
+67% +$10.4K ﹤0.01% 5297
2015
Q1
$11K Sell
9
-32
-78% -$39.1K ﹤0.01% 5819
2014
Q4
$41K Buy
+41
New +$41K ﹤0.01% 4898